Similar articles for PMID: 18342519

Year	Number of Results
1997	1
2002	1
2004	2
2005	3
2006	1
2007	3
2008	19
2009	20
2010	4
2011	4
2013	3
2014	2
2016	1
2017	3
2018	1
2019	1
2022	1
2024	0

1

Computational modeling study of functional microdomains in cannabinoid receptor type 1.

Gonzalez A, Duran LS, Araya-Secchi R, Garate JA, Pessoa-Mahana CD, Lagos CF, Perez-Acle T. Gonzalez A, et al. Bioorg Med Chem. 2008 Apr 15;16(8):4378-89. doi: 10.1016/j.bmc.2008.02.070. Epub 2008 Feb 26. Bioorg Med Chem. 2008. PMID: 18342519

2

Homology models of the cannabinoid CB1 and CB2 receptors. A docking analysis study.

Montero C, Campillo NE, Goya P, Páez JA. Montero C, et al. Eur J Med Chem. 2005 Jan;40(1):75-83. doi: 10.1016/j.ejmech.2004.10.002. Eur J Med Chem. 2005. PMID: 15642412

3

Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor.

Hudson BD, Hébert TE, Kelly ME. Hudson BD, et al. Mol Pharmacol. 2010 Jan;77(1):1-9. doi: 10.1124/mol.109.060251. Epub 2009 Oct 16. Mol Pharmacol. 2010. PMID: 19837905 Review.

4

The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2.

Durdagi S, Kapou A, Kourouli T, Andreou T, Nikas SP, Nahmias VR, Papahatjis DP, Papadopoulos MG, Mavromoustakos T. Durdagi S, et al. J Med Chem. 2007 Jun 14;50(12):2875-85. doi: 10.1021/jm0610705. Epub 2007 May 24. J Med Chem. 2007. PMID: 17521177

5

Development of a 3D model for the human cannabinoid CB1 receptor.

Salo OM, Lahtela-Kakkonen M, Gynther J, Järvinen T, Poso A. Salo OM, et al. J Med Chem. 2004 Jun 3;47(12):3048-57. doi: 10.1021/jm031052c. J Med Chem. 2004. PMID: 15163186

6

Homology modeling and molecular dynamics simulations of the mu opioid receptor in a membrane-aqueous system.

Zhang Y, Sham YY, Rajamani R, Gao J, Portoghese PS. Zhang Y, et al. Chembiochem. 2005 May;6(5):853-9. doi: 10.1002/cbic.200400207. Chembiochem. 2005. PMID: 15776407

7

3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data.

Salo OM, Savinainen JR, Parkkari T, Nevalainen T, Lahtela-Kakkonen M, Gynther J, Laitinen JT, Järvinen T, Poso A. Salo OM, et al. J Med Chem. 2006 Jan 26;49(2):554-66. doi: 10.1021/jm0505157. J Med Chem. 2006. PMID: 16420041

8

Novel sterically hindered cannabinoid CB1 receptor ligands.

Urbani P, Cascio MG, Ramunno A, Bisogno T, Saturnino C, Di Marzo V. Urbani P, et al. Bioorg Med Chem. 2008 Aug 1;16(15):7510-5. doi: 10.1016/j.bmc.2008.06.001. Epub 2008 Jun 7. Bioorg Med Chem. 2008. PMID: 18579386

9

Synthesis, cannabinoid receptor affinity, molecular modeling studies and in vivo pharmacological evaluation of new substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 2. Effect of the 3-carboxamide substituent on the affinity and selectivity profile.

Silvestri R, Ligresti A, La Regina G, Piscitelli F, Gatti V, Brizzi A, Pasquini S, Lavecchia A, Allarà M, Fantini N, Carai MA, Novellino E, Colombo G, Di Marzo V, Corelli F. Silvestri R, et al. Bioorg Med Chem. 2009 Aug 1;17(15):5549-64. doi: 10.1016/j.bmc.2009.06.027. Epub 2009 Jun 21. Bioorg Med Chem. 2009. PMID: 19595596

10

Exploring a model of a chemokine receptor/ligand complex in an explicit membrane environment by molecular dynamics simulation: the human CCR1 receptor.

Shahlaei M, Madadkar-Sobhani A, Fassihi A, Saghaie L. Shahlaei M, et al. J Chem Inf Model. 2011 Oct 24;51(10):2717-30. doi: 10.1021/ci200261f. Epub 2011 Sep 28. J Chem Inf Model. 2011. PMID: 21910472

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

63 results

Results by year